MCAD stands for medium-chain acyl-CoA dehydrogenase.
What does MCAD stand for?
MCAD stands for Medium-Chain Acyl-CoA Dehydrogenase (inherited metabolic disease)
This definition appears very frequently and is found in the following Acronym Finder categories:
- Science, medicine, engineering, etc.
See other definitions of MCAD
We have 43 other meanings of MCAD in our Acronym Attic
- Mohawk College Association of Continuing Education Students (Canada)
- Mechanical Contractors Association of Central Ohio (Columbus, OH)
- Masonry Contractors Association of Central Pennsylvania (Elysburg, PA)
- Massachusetts Chapter of the American College of Surgeons (Beverly, MA)
- Michigan Chapter of the American College of Surgeons (est. 1951)
- Macon County Ambulance District (Macon, MO)
- Marine Corps Air Depot (US DoD)
- Massachusetts Commission Against Discrimination
- Maximum-Connection-Availability Design
- Mechanical Computer Aided Design
- Microsoft Certified Application Designer
- Microsoft Certified Application Developer
- Military Crew Advisor
- Minneapolis College of Art and Design (Minneapolis, MN, USA)
- Mobile Chemical Agent Detector
- Montgomery County Appraisal District (Montgomery County, Texas)
- Mercer Council on Alcoholism and Drug Addiction (New Jersey)
- Mercer County Agricultural Development Board (est. 1983; New Jersey)
- Middlesex County Agriculture Development Board (New Jersey)
- Monmouth County Agriculture Development Board (New Jersey)
Samples in periodicals archive:
Medium-chain acyl-CoA dehydrogenase deficiency (MCADD)  leads to the accumulation of octanoylcarnitine (C8) in the blood and can be diagnosed by analysis of the concentration of acylcarnitines by use of tandem mass spectrometry (MS/MS) (1).
Newborn blood spot The newborn blood spot (also known as 'heel prick') screens for phenylketonuria, congenital hypothyroidism, sickle cell disease, cystic fibrosis and medium-chain acyl-CoA dehydrogenase deficiency (MCADD).
Medium-chain Acyl-CoA dehydrogenase (MCAD) deficiency is an inherited enzyme deficiency.
For example, for medium-chain acyl-CoA dehydrogenase deficiency (MCADD), the ratios of acylcarnitines C8:C10, C8:C6, C8:C2, and C8:C12 have proven useful (1-5).
He was among the first to describe the fatal clinical phenotype and the first to identify neonatal metabolite abnormalities in medium-chain acyl-CoA dehydrogenase (MCAD) deficiency.